ArticleFrontiers in oncology2026

Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC.

Lorenzo De Sanctis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.